SLL (SMALL LYMPHOCYTIC LYMPHOMA)
Clinical trials for SLL (SMALL LYMPHOCYTIC LYMPHOMA) explained in plain language.
Never miss a new study
Get alerted when new SLL (SMALL LYMPHOCYTIC LYMPHOMA) trials appear
Sign up with your email to follow new studies for SLL (SMALL LYMPHOCYTIC LYMPHOMA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug showdown for Tough-to-Treat blood cancer
Disease control Not yet recruitingThis study aims to find out which of two daily pill treatments works better for adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) that has come back or stopped responding to a previous standard treatment. About 306 participants will be randomly as…
Matched conditions: SLL (SMALL LYMPHOCYTIC LYMPHOMA)
Phase: PHASE3 • Sponsor: Newave Pharmaceutical Inc • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New drug tested for Tough-to-Treat blood cancer
Disease control Not yet recruitingThis early-stage study is testing a new drug called MS-553 in adults with chronic lymphocytic leukemia or small lymphocytic lymphoma that has returned or stopped responding to previous treatments. The main goal is to check the drug's safety and side effects in about 12 patients. …
Matched conditions: SLL (SMALL LYMPHOCYTIC LYMPHOMA)
Phase: PHASE1, PHASE2 • Sponsor: MingSight Pharmaceuticals, Inc • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC